Lubricants can retard disintegration and dissolution of pharmaceutical tablets and capsules due to their:
Disintegration Retardation:
1. Hydrophobicity: Lubricants create a water-repellent barrier, slowing water penetration and tablet disintegration.
2. Surface tension reduction: Lubricants decrease surface tension, making it harder for water to penetrate the tablet.
3. Tablet hardness increase: Lubricants can strengthen tablet bonds, making disintegration more difficult.
Dissolution Retardation:
1. Reduced wettability: Lubricants decrease tablet surface wettability, slowing dissolution.
2. Increased hydrophobicity: Lubricants enhance hydrophobic interactions, slowing drug release.
3. Formation of hydrophobic films: Lubricants can create films around particles, hindering dissolution.
Lubricant Properties Affecting Disintegration/Dissolution:
1. Type (e.g., hydrophobic vs. hydrophilic)
2. Concentration
3. Particle size
4. Melting point
5. Solubility
Common Offending Lubricants:
1. Magnesium stearate
2. Stearic acid
3. Silicones (e.g., dimethicone)
4. Glyceryl behenate
Mitigation Strategies:
1. Optimize lubricant concentration
2. Choose hydrophilic lubricants (e.g., PEG)
3. Use alternative lubrication methods (e.g., nano-lubricants)
4. Reformulate tablets/capsules for better wettability
5. Apply coating or surface modification techniques
Regulatory Considerations:
1. FDA guidelines (21 CFR)
2. EU regulations (EU GMP)
3. Compliance with pharmacopeial standards (e.g., USP, EP)
Understanding lubricant effects on disintegration and dissolution helps formulation scientists optimize tablet/capsule design, ensuring timely drug release and efficacy.